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To the Editor: I read with interest the article by Sugimoto
and colleagues.1 Hypertension, a common cause and
complication of patients with end-stage renal disease
requiring dialysis, is not mentioned in the article. Although
Helicobacter pylori infection is significantly associated with
higher systolic blood pressure, there is no association
between H. pylori infection and fasting blood glucose.2 If
the authors had controlled for hypertension in the study, the
prevalence of H. pylori infection in the population might
have been different.
1. Sugimoto M, Sakai K, Kita M et al. Prevalence of Helicobacter pylori
infection in long-term hemodialysis patients. Kidney Int 2009; 75: 96–103.
2. Gunji T, Matsuhashi N, Sato H et al. Helicobacter pylori infection is
significantly associated with metabolic syndrome in the Japanese
population. Am J Gastroenterol 2008; 103: 3005–3010.
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We thank Dr Kittisupamongkol for his useful comments
about the association between Helicobacter pylori infection
and hypertension in dialysis.1 Hypertension is known to be
a common cause and/or complication of dialysis patients,
and many patients enrolled in our study had hyperten-
sion.2 H. pylori infection is reportedly involved in the
development of not only gastroduodenal diseases but also
metabolic syndromes and cardiovascular diseases, such as
hypertension, angina pectoris, and arteriosclerosis.3 How-
ever, there are several reports that H. pylori infection
prevents metabolic syndromes and hypertension. For
example, Furuta et al.4 reported that after H. pylori
infection was cured body weight and serum levels of
total cholesterol, total protein, and albumin increased
significantly.
In our study, the prevalence of H. pylori infection was
equal in all patients irrespective of renal function, whereas
dialysis patients had a higher rate of hypertension than did
patients with normal renal function. Moreover, the
prevalence of H. pylori infection in dialysis patients with
treatment periods of less than one year was significantly
higher than that in patients with treatment periods of
more than 5 years, although the prevalence of hypertension
was unchanged by the treatment periods. These observa-
tions clearly showed that hypertension has no direct effects
on the disappearance of H. pylori infection.
Overall, the direct association between H. pylori
infection and hypertension is controversial, and it also
remains uncertain how H. pylori infection affects the
pathogenic process leading to hypertension. Further study
will be required to clarify the association and mechanism.
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